Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06931535Recruiting
Arm cuff treatment for recent moderate back-of-brain stroke
This trial tests whether a simple, non-drug treatment (using a blood pressure cuff to briefly restrict blood flow to your arm) can help people with a recent moderate stroke in the back part of the brain. It aims to improve recovery by preparing the body to better handle the stroke damage.
ShenyangAges 18 years+ - NCT06931782Enrolling by invitation
AI for respiratory disease screening study
This trial tests whether an artificial intelligence (AI) tool can help prevent, diagnose, and triage respiratory diseases. It is open to adults without medical training who can follow a survey.
Guangzhou, GuangdongAges 18–75 - NCT06926140Recruiting
Acupuncture with immunotherapy for advanced lung cancer
This trial tests if adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced lung cancer. It is for those who have not had treatment before and whose tumors have low PD-L1 levels.
Hefei, AnhuiAges 18–75 - NCT06925334Enrolling by invitationPhase 4
Comparing a new insulin combo with premixed insulin for type 2 diabetes
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
Beijing, Beijing MunicipalityAges 18–75 - NCT06922669Recruiting
Steroids for drug-induced liver injury with high bilirubin
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
Shenyang, LiaoningAges 18–80 - NCT06927804Recruiting
Virtual reality for comfort during port placement
This trial tests whether using virtual reality (a headset showing calming images) can help patients feel more comfortable and less distressed while having a small device (a port) inserted under the skin for chemotherapy or other cancer treatments.
Ostrava, Moravian-Silesian RegionAges 18 years+ - NCT06926751RecruitingPhase 2
Preventing low white blood cell counts in kids with solid tumors
This trial compares two drugs (Telpegfilgrastim and Filgrastim) to help prevent dangerously low white blood cell counts after chemotherapy in children and young adults with solid tumors. It's for patients who have already had this problem in a previous chemo round.
BeijingAges 6–24 - NCT06930391Recruiting
How calcium affects a drug that helps the uterus contract
This trial tests if adding calcium changes how well a drug called carbetocin works to make the uterus contract after a planned C-section. It may help doctors prevent heavy bleeding after delivery.
Toronto, OntarioAges 18–40 - NCT06923826RecruitingPhase 2
Study of sacituzumab govitecan for advanced salivary gland and thyroid cancers
This trial tests a drug called sacituzumab govitecan in people with advanced salivary gland cancer or thyroid cancer that has spread or cannot be removed. The goal is to see if the drug can help shrink or slow down the cancer.
SingaporeAges 21 years+ - NCT06923878Recruiting
Legume allergy diagnosis study with skin and blood tests
This study compares different tests to diagnose legume allergies. They look at skin prick tests, blood tests for IgE antibodies, and component-resolved diagnosis to see which works best for peas, lentils, chickpeas, and beans.
Pilsen, Czech RepublicAges 4 months–65 years - NCT06923865Enrolling by invitation
Exercise program for overweight teens
This trial tests whether a supervised exercise program can improve movement skills and motivation in overweight adolescents. It is designed for teens who struggle with physical activity but are otherwise healthy.
BaselAges 12–14 - NCT06928376RecruitingPhase 2
Venetoclax plus chemo vs standard chemo for AML
This trial tests a new combination of venetoclax plus a chemotherapy regimen (called CACAG) against a standard chemotherapy regimen (3+7) for adults with newly diagnosed intermediate- or high-risk AML. The goal is to see if the new combination works better.
Beijing, Beijing MunicipalityAges 14–75 - NCT06924697Enrolling by invitation
Testing a diabetes drug to help men quit smoking
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06927102Recruiting
Bringing back breast cancer patients lost to follow-up
This study looks at people with breast cancer who stopped coming to follow-up appointments. It aims to understand why they dropped out and help them re-engage with care.
Hyderabad, TelanganaAges 18 years+ - NCT06930885RecruitingPhase 3
Polypill and colchicine for heart and artery risk
This trial tests a combination pill (polypill) and a medicine called colchicine to see if they can lower the risk of future heart attacks, strokes, or other artery problems. It is for people who already have a history of heart or blood vessel disease.
Maceió, AlabamaAges 45 years+ - NCT06929091Recruiting
Breastfeeding help for women with higher weight
This study tests if expressing milk before birth and following a meal plan after birth helps women with higher weight breastfeed longer. You may join if you are pregnant, interested in breastfeeding, and live in Central Arkansas.
Little Rock, ArkansasAges 18 years+ - NCT06930690RecruitingPhase 1/Phase 2
Dexamethasone for ureteral stent symptoms trial
This trial tests whether a single dose of dexamethasone, given before stent placement, can reduce pain, urgency, and discomfort caused by ureteral stents after kidney stone surgery. If you are having a stent placed during ureteroscopy, you may qualify.
Houston, TexasAges 18–70 - NCT06927076Recruiting
DMT with propofol for depression
This study tests whether a combination of DMT (a psychedelic) and propofol (a sedative) can help treat depression. You will receive both medicines in a hospital setting, and the team will monitor your response.
BaselAges 21 years+ - NCT06931444Enrolling by invitation
Children's eye study in Beijing
This study will follow healthy primary school students for several years to understand how children's eyes develop and how to prevent vision problems. It involves a simple eye exam with drops to check for any issues.
Beijing, Beijing MunicipalityAges 6–12 - NCT06930131Recruiting
Word-finding therapy with thinking skills training after stroke
This study tests a new talking therapy for people with word-finding problems after a stroke. It combines exercises to help you find words with training to think about how you learn and remember them.
ToulouseAges 18 years+ - NCT06923202Recruiting
Studying alloknesia in atopic dermatitis
This study looks at a condition called alloknesia (a feeling that a light touch is painful) in people with atopic dermatitis (a type of eczema). It aims to understand how common this is and what it feels like.
AngersAges 18 years+ - NCT06931457Recruiting
Radiofrequency with platelet injection for nerve pain in the throat
This study tests if combining pulsed radiofrequency (a treatment that uses heat to calm nerve pain) with a platelet injection (using your own blood to help healing) is safe and works better for treating throat nerve pain (glossopharyngeal neuralgia) than radiofrequency alone.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06924710Recruiting
Adaptive therapy for early stage lung cancer with no MRD detected
This study tests a new approach for people with early-stage non-small cell lung cancer (NSCLC) who have had their tumor completely removed. It uses regular blood tests (MRD monitoring) to watch for any cancer cells left behind, so treatment can be given only if needed.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06928922RecruitingEarly Phase 1
Inhaled mRNA vaccine for advanced lung cancer and lung metastases
This trial tests an inhaled dry powder vaccine that uses mRNA to help your immune system target cancer cells in the lungs. It is for people with advanced lung cancer or solid tumors that have spread to the lungs, who have already tried standard treatments.
BeijingAges Up to 99 years
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,157 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.